Survival of patients with metastatic renal cell carcinoma with or without brain metastases
In our ccRCC population, OS for patients with metastatic ccRCC and brain metastases has improved in the era of ICI therapy. Brain metastases are associated with poor prognosis. Patients with brain metastases discovered on screening had improved overall survival compared to those with brain metastases discovered because of symptoms.
Authors
- Harriet M. Kluger (ORCID: https://orcid.org/0000-0002-4932-9873)
- David A. Schoenfeld (ORCID: https://orcid.org/0000-0002-5202-3744)
- Melanie Nelson (ORCID: https://orcid.org/0000-0003-3325-0949)
- Veronica Chiang (ORCID: https://orcid.org/0000-0003-1882-3876)
- David A. Braun (ORCID: https://orcid.org/0000-0003-4543-5553)
- Michael Leapman (ORCID: https://orcid.org/0000-0002-0727-7614)
- Michael E. Hurwitz (ORCID: https://orcid.org/0000-0002-1326-7308)
- Bryden Considine (ORCID: https://orcid.org/0000-0003-4169-0311)
- Noam Savion‐Gaiger (ORCID: https://orcid.org/0000-0002-5638-1151)
- Mario Sznol (ORCID: https://orcid.org/0000-0003-4137-9662)
- Nitzan Hasson
Institutions
- Yale New Haven Hospital (US)
- Yale Cancer Center (US)
- Yale University (US)
Publication Details
- Journal
- The Oncologist
- Published
- 2025-11-23
- DOI
- https://doi.org/10.1093/oncolo/oyaf387
- Primary Topic
- Brain Metastases and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00